EDC:ARCA-Direxion Emerging Markets Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 32.88

Change

-0.68 (-2.03)%

Market Cap

USD 0.17B

Volume

0.08M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the MSCI Emerging Markets IndexSM. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the MSCI Emerging Markets IndexSM and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets. The fund is non-diversified.

Inception Date: 17/12/2008

Primary Benchmark: MSCI EM GR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.96%

Management Expense Ratio: 0.98 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
EEM iShares MSCI Emerging Markets ETF 7.73 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+1.62 (+5.09%)

USD 8.48B
QLD ProShares Ultra QQQ 0.95 %

+0.76 (+0.80%)

USD 5.39B
SSO ProShares Ultra S&P500 0.90 %

+0.83 (+0.97%)

USD 4.50B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+5.69 (+1.47%)

USD 4.11B
UPRO ProShares UltraPro S&P500 0.92 %

+1.17 (+1.47%)

USD 3.53B
TECL Direxion Daily Technology Bull.. 1.17 %

+1.16 (+1.44%)

USD 2.51B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

+8.40 (+6.43%)

USD 0.94B
USD ProShares Ultra Semiconductors 0.95 %

+1.59 (+1.42%)

USD 0.86B
DPST Direxion Daily Regional Banks .. 1.02 %

+6.91 (+7.83%)

USD 0.77B
YINN Direxion Daily FTSE China Bull.. 1.02 %

+0.33 (+1.60%)

USD 0.71B

ETFs Containing EDC

SCHZ Schwab U.S. Aggregate Bon.. 0.00 % 0.04 %

+0.06 (+0.13%)

USD 8.44B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.05% 27% F 57% F
Dividend Return 2.50% 98% N/A 54% F
Total Return 10.55% 35% F 58% F
Trailing 12 Months  
Capital Gain 10.86% 27% F 54% F
Dividend Return 4.05% 97% N/A 57% F
Total Return 14.91% 29% F 54% F
Trailing 5 Years  
Capital Gain -47.31% 23% F 10% F
Dividend Return 3.28% 48% F 9% A-
Total Return -44.03% 22% F 9% A-
Average Annual (5 Year Horizon)  
Capital Gain 0.95% 22% F 43% F
Dividend Return 1.98% 22% F 37% F
Total Return 1.04% 71% C- 23% F
Risk Return Profile  
Volatility (Standard Deviation) 67.66% 57% F 12% F
Risk Adjusted Return 2.93% 19% F 28% F
Market Capitalization 0.17B 45% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.